55
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

Page 7919 | Published online: 27 Sep 2019
This article refers to:
Targeted delivery of doxorubicin to HER2 positive tumor models

Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.

The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.

Acknowledgments

The authors wish to thank Tarbiat Modares University for partially funding the project. This study is a part of the PhD thesis of Hosna Gomari, Tarbiat Modares University, Tehran, Iran.

Should be updated to read:

Acknowledgments

The authors wish to thank Tarbiat Modares University for partially funding the project. The authors would also like to thank Ms Brigitte Langer from the Department of Pathology, Medical University of Vienna, Austria for performing TEM on isolated exosomes in Pathology Department and for providing the TEM image (Figure 2A). This study is a part of the PhD thesis of Hosna Gomari, Tarbiat Modares University, Tehran, Iran.